Remove Community Remove Complication Remove Diabetes Remove Hospital
article thumbnail

Diabetes related complications among Ethiopian Jews-Outcomes of a 10 years cohort study in Israel [Population health and epidemiology]

Annals of Family Medicine

The context: Immigrants, particularly those moving from lower to higher-income countries, often exhibit a heightened susceptibility to non-communicable diseases, such as Type 2 diabetes (T2D), which may manifest at an earlier age and present with different complications compared to the native population. 0.83, HR 0.70; 95% CI 0.65-0.76,

article thumbnail

SGLT-2 inhibitor, cardiovascular risk and outcome in patients with comorbidity of hypertension and diabetes [Cardiovascular disease]

Annals of Family Medicine

Context Two thirds of diabetes patients complicated with hypertension, and comorbidity increase 4-fold risk of atherosclerotic cardiovascular disease (ASCVD). Setting or Dataset Five electronic systems of community clinic. Population Studied individuals with comorbidity of hypertension and type 2 diabetes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Diabetes in Late Life: Nadine Carter, Tamryn Gray, Alex Lee

GeriPal

Summary Transcript Summary Diabetes is common. When I’m on palliative care consults and attending in our hospice unit we have to counsel patients about deprescribing and de-intensifying diabetes medications. And yet we’re also in a different place in diabetes monitoring and management. Goldilocks zone). This is Eric Widera.

article thumbnail

Reasoning during the COVID-19 pandemic

The Clinical Problem Solvers

No prior history of atrial fibrillation – just hypertension and diabetes. The second major factor complicating our diagnostic reasoning during this time is the dramatic shift in prevalence of the disease in the community. It started off like any other cardiology admission that we’d had during that month.

Illness 52
article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. Maybe even had come in with a complication.

article thumbnail

Feasibility and Acceptability of the Diabetes Homelessness Medication Support (D-Homes) Program for Spanish Speaking People [Diabetes and endocrine disease]

Annals of Family Medicine

Context: People experiencing homelessness (PEH) and type 2 diabetes are hospitalized more often, develop diabetes complications, and die on average 10 years earlier than their housed peers due to poorly controlled chronic physical and behavioral health conditions.

Diabetes 130
article thumbnail

Is a GLP-1 Receptor Agonist right for me?

Vida Family Medicine

In reality, GLP-1 receptor agonists have been available for many years for the treatment of type 2 diabetes (Victoza, Trulicity, etc) and for weight loss (Saxenda), while tirzepatide is new in the last few years. Sometimes these conditions can be controlled with lifestyle changes alone, but not all of these risk factors are under our control.